BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Report Library

All Reports
Datamonitor Healthcare Oncology: Basal Cell Carcinoma Market Spotlight

March 04, 2020

Basal cell carcinoma (BCC), a non-melanoma skin cancer (NMSC), is the most common form of skin cancer, accounting for 75–80% of all skin cancers. BCCs are uncontrolled and abnormal growths that arise in the basal cells of the skin. The tumors primarily affect photoexposed areas, most commonly in the head, and rarely appear on perigenital and genitalia regions. The disease progression is slow and metastases can be seen in <0.5% of BCC cases; however, it can be locally disfiguring and destructive. BCC is more common in fair-skinned people with a genetic history of the condition, and incidence increases when these individuals are located at higher altitudes or closer to the equator.

This Datamonitor Healthcare report contains a Market Spotlight module.
Indications Covered: Skin Cancer - Basal Cell Carcinoma (BCC)
Back to the top Back to the top